Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Ticklel1ston Dec 07, 2020 7:15pm

122 Views

Post# 32054859

RE:RE:RE:RE:management

Waxie...Yah, I used to think She was the only one that actually brought any value to this mess. But the fact is, the patents are the saleable items here and as far as I can see, none have been mometized to any benefit of shareholders.

So...to me, the lab is just a money pit. I mean, what do they do there everyday? Was coffed cups and make like chemists doing it? Or maybe they are all parttimers like Howhee and the rest of the Sirona management ...work a couple of hours here and there and grab some bonus money.

Bullboard Posts

Abcourt Mines launches Flordin property drill campaign